Diet-Induced Obesity Alters Dendritic Cell Function in the Presence and Absence of Tumor Growth
Authors:
- 1 August 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 189 (3) , 1311-1321
Abstract
Obesity is a mounting health concern in the United States and is associated with an increased risk for developing several cancers, including renal cell carcinoma (RCC). Despite this, little is known regarding the impact of obesity on antitumor immunity. Because dendritic cells (DC) are critical regulators of antitumor immunity, we examined the combined effects of obesity and tumor outgrowth on DC function. Using a diet-induced obesity (DIO) model, DC function was evaluated in mice bearing orthotopic RCC and in tumor-free controls. Tumor-free DIO mice had profoundly altered serum cytokine and chemokine profiles, with upregulation of 15 proteins, including IL-1α, IL-17, and LIF. Tumor-free DIO mice had elevated percentages of conventional splenic DC that were impaired in their ability to stimulate naive T cell expansion, although they were phenotypically similar to normal weight (NW) controls. In DIO mice, intrarenal RCC tumor challenge in the absence of therapy led to increased local infiltration by T cell-suppressive DC and accelerated early tumor outgrowth. Following administration of a DC-dependent immunotherapy, established RCC tumors regressed in normal weight mice. The same immunotherapy was ineffective in DIO mice and was characterized by an accumulation of regulatory DC in tumor-bearing kidneys, decreased local infiltration by IFN-γ–producing CD8 T cells, and progressive tumor outgrowth. Our results suggest that the presence of obesity as a comorbidity can impair the efficacy of DC-dependent antitumor immunotherapies.Keywords
This publication has 67 references indexed in Scilit:
- Lipid accumulation and dendritic cell dysfunction in cancerNature Medicine, 2010
- Epidemiology and risk factors for kidney cancerNature Reviews Urology, 2010
- Temporal changes in dendritic cell subsets, cross-priming and costimulation via CD70 control CD8+ T cell responses to influenzaNature Immunology, 2010
- TNF-related apoptosis-inducing ligand (TRAIL): A new path to anti-cancer therapiesEuropean Journal of Pharmacology, 2009
- Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasisNature, 2009
- Cancer-related inflammationNature, 2008
- Inflammation and metabolic disordersNature, 2006
- Overweight, obesity and cancer: epidemiological evidence and proposed mechanismsNature Reviews Cancer, 2004
- Inflammation and necrosis promote tumour growthNature Reviews Immunology, 2004
- Inflammation and cancerNature, 2002